RAC1 and central nervous system cancer: RhoG can also activate Rac1 and Cdc42 in the regulation of neuronal process plasticity (80, 81), thus it remains a possibility that deregulated neuronal signaling and development pathways may also utilize RhoG to promote glioma malignancy.